116 related articles for article (PubMed ID: 12175895)
1. Fumonisin B(1) alters sphingolipid metabolism and tumor necrosis factor alpha expression in heart and lung of mice.
He Q; Bhandari N; Sharma RP
Life Sci; 2002 Sep; 71(17):2015-23. PubMed ID: 12175895
[TBL] [Abstract][Full Text] [Related]
2. Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases.
He Q; Kim J; Sharma RP
Toxicol Sci; 2004 Aug; 80(2):335-42. PubMed ID: 15103051
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase.
Suzuki H; Riley RT; Sharma RP
Toxicology; 2007 Jan; 229(1-2):42-53. PubMed ID: 17095132
[TBL] [Abstract][Full Text] [Related]
4. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
He Q; Riley RT; Sharma RP
Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
[TBL] [Abstract][Full Text] [Related]
6. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
Tsunoda M; Sharma RP; Riley RT
J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
[TBL] [Abstract][Full Text] [Related]
7. Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice.
Bhandari N; He Q; Sharma RP
Toxicology; 2001 Aug; 165(2-3):195-204. PubMed ID: 11522378
[TBL] [Abstract][Full Text] [Related]
8. Fumonisin B(1)-induced alterations in cytokine expression and apoptosis signaling genes in mouse liver and kidney after an acute exposure.
Bhandari N; Sharma RP
Toxicology; 2002 Mar; 172(2):81-92. PubMed ID: 11882348
[TBL] [Abstract][Full Text] [Related]
9. Temporal expression of fumonisin B(1)-induced tumor necrosis factor-alpha and interferon gamma in mice.
Bhandari N; Enongene EN; Riley RT; Meredith FI; Sharma RP
Comp Biochem Physiol C Toxicol Pharmacol; 2002 Feb; 131(2):113-22. PubMed ID: 11879779
[TBL] [Abstract][Full Text] [Related]
10. Deletion of IFN-gamma reduces fumonisin-induced hepatotoxicity in mice via alterations in inflammatory cytokines and apoptotic factors.
Sharma RP; He Q; Johnson VJ
J Interferon Cytokine Res; 2003 Jan; 23(1):13-23. PubMed ID: 12639295
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): a model for reducing fumonisin-induced nephrotoxicity in vivo.
He Q; Riley RT; Sharma RP
Pharmacol Toxicol; 2002 May; 90(5):268-77. PubMed ID: 12076308
[TBL] [Abstract][Full Text] [Related]
12. Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks.
Turner PC; Nikiema P; Wild CP
Mutat Res; 1999 Jul; 443(1-2):81-93. PubMed ID: 10415433
[TBL] [Abstract][Full Text] [Related]
13. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase.
Enongene EN; Sharma RP; Bhandari N; Miller JD; Meredith FI; Voss KA; Riley RT
Toxicol Sci; 2002 Jun; 67(2):173-81. PubMed ID: 12011476
[TBL] [Abstract][Full Text] [Related]
14. Identification of differentially expressed genes following treatment of monkey kidney cells with the mycotoxin fumonisin B(1).
Zhang Y; Jones C; Dickman MB
Food Chem Toxicol; 2001 Jan; 39(1):45-53. PubMed ID: 11259850
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor necrosis factor alpha signaling by anti-tumor necrosis factor alpha antibodies and pentoxifylline is unable to prevent fumonisin hepatotoxicity in mice.
He Q; Sharma RP
Toxicon; 2005 Sep; 46(4):404-13. PubMed ID: 16054185
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to fumonisin toxicity in a mouse strain lacking the P75 tumor necrosis factor receptor.
Sharma RP; Bhandari N; Riley RT; Voss KA; Meredith FI
Toxicology; 2000 Feb; 143(2):183-94. PubMed ID: 10755704
[TBL] [Abstract][Full Text] [Related]
18. Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B(1).
Enongene EN; Sharma RP; Bhandari N; Voss KA; Riley RT
Food Chem Toxicol; 2000 Sep; 38(9):793-9. PubMed ID: 10930700
[TBL] [Abstract][Full Text] [Related]
19. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships.
Norred WP; Plattner RD; Dombrink-Kurtzman MA; Meredith FI; Riley RT
Toxicol Appl Pharmacol; 1997 Nov; 147(1):63-70. PubMed ID: 9356308
[TBL] [Abstract][Full Text] [Related]
20. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
He Q; Riley RT; Sharma RP
Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
